CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$33.97
+0.65 (+1.95%)
Open$34.94
Previous Close$33.32
Day High$34.94
Day Low$32.62
52W High$35.79
52W Low$17.85
Volume—
Avg Volume651.0K
Market Cap2.67B
P/E Ratio—
EPS$-3.90
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+53.3% upside
Current
$33.97
$33.97
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.83M | 2.11M | 613.37M |
| Net Income | -305,668,686 | -316,828,074 | -4,777,656 |
| Profit Margin | -16,748.0% | -15,910.6% | -0.8% |
| EBITDA | -335,468,970 | -367,033,884 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | -13.2% | -13.2% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |